-
1دورية أكاديمية
المؤلفون: Barr, Adele M.Aff1, Silva, Anabel, Prato, Sandro, Belz, Gabrielle T.Aff2, Aff3, Aff4, Maraskovsky, Eugene, Baz Morelli, AdrianaAff1
المصدر: Cancer Immunology, Immunotherapy. 69(10):1959-1972
-
2
المؤلفون: Anabel Silva, Adriana Baz Morelli, Adele M. Barr, Eugene Maraskovsky, Gabrielle T. Belz, Sandro Prato
المصدر: Cancer Immunology, Immunotherapy
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_treatment, Melanoma, Experimental, TRAMPC1, Apoptosis, NK cells, CD8-Positive T-Lymphocytes, Mice, Prostate cancer, Tumor Cells, Cultured, Tumor Microenvironment, Immunology and Allergy, Phospholipids, Adjuvant, Tumor antigen, Drug Combinations, Cholesterol, Oncology, Prostatic acid phosphatase, Original Article, Ovalbumin, Immunology, Cancer Vaccines, Interferon-gamma, Adjuvants, Immunologic, Antigens, Neoplasm, medicine, Animals, Humans, Cell Proliferation, Tumor microenvironment, business.industry, Membrane Proteins, Prostatic Neoplasms, Cancer, Immunotherapy, Saponins, Therapeutic vaccine, medicine.disease, Xenograft Model Antitumor Assays, CD4+ T cells, Mice, Inbred C57BL, Disease Models, Animal, Poly I-C, Cancer research, Cancer vaccine, business
-
3
المؤلفون: Juan de Dios Berná-Mestre, A. Olivares, Miguel Alcaraz, Daniel Gyingiri Achel, Miguel Alcaraz-Saura
المصدر: Antioxidants
Volume 10
Issue 2
Antioxidants, Vol 10, Iss 231, p 231 (2021)مصطلحات موضوعية: 0301 basic medicine, rosmarinic acid, Physiology, Clinical Biochemistry, TRAMPC1, Pharmacology, Biochemistry, Article, Lipid peroxidation, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, PNT2, In vivo, Bystander effect, Cytotoxic T cell, micronucleus, Molecular Biology, bystander, Chemistry, B16F10, radioprotectors, lcsh:RM1-950, In vitro toxicology, Cell Biology, In vitro, 030104 developmental biology, lcsh:Therapeutics. Pharmacology, Cell culture, 030220 oncology & carcinogenesis, Micronucleus test, radiation effects
وصف الملف: application/pdf
-
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.